Document:

Adamis Pharmaceuticals Corporation 10-Q

     

Exhibit 10.1

 

*** Certain identified information has
been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant
if publicly disclosed. Such omitted information is indicated by brackets (“[...***...]” in this exhibit.
***

 

TERMINATION AND TRANSFER AGREEMENT

 

This Termination and Transfer
Agreement (this “Agreement”) is made and entered into as of May 11, 2020 (the “Effective Date”)
by and between Adamis Pharmaceuticals Corporation (“Adamis”), a corporation organized under the laws of Delaware
(the “Company”), with an office located at 11682 El Camino Real, Suite #300, San Diego, CA 92130 and Sandoz Inc. (“Sandoz”)
with an address at 100 College Road, West Princeton, NJ 08540. Sandoz and Adamis may each be
referred to herein as a “Party” or, collectively, as the “Parties.”

 

WHEREAS, the Parties
previously entered into a Distribution and Commercialization Agreement effective as of July 1, 2018 (the “Commercialization
Agreement”);

 

WHEREAS, the Parties
desire to terminate the Commercialization Agreement on the Termination Date (defined herein) and enter into this Agreement to provide
for the transition of certain materials and activities to Adamis on or prior to the Termination Date; and

 

WHEREAS, all capitalized
terms used but not defined herein shall have the meanings ascribed to them in the Commercialization Agreement.

 

NOW, THEREFORE, in
consideration of the following mutual promises and obligations, and for other good and valuable consideration, the adequacy and
sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

1.            Termination. Notwithstanding anything to the contrary contained in the Transition Services Agreement, the Commercial Agreement
is hereby terminated, effective as of the Termination Date.

 

2.            Transfer. During the period beginning on the date hereof and ending on [***] (the “Termination Date”),
the Parties shall use Commercially Reasonable Efforts to transition to Adamis [***] (the “Transfer Period”).
Without limiting the generality of the foregoing, during the Transfer Period:

 

(a)          Upon the date hereof Sandoz shall provide to Adamis [***].

 

(b)          Sandoz shall use Commercially Reasonable Efforts to transfer to Adamis ownership and control of all Marketing Materials produced
as of the Effective Date and before the Termination Date by or on behalf of Sandoz, its Affiliates and relating to the Products
and any other materials, as set forth on Exhibit A. “Marketing Materials” includes all marketing materials
relating to the Products including, without limitation, [***]. Adamis agrees that it or its designee shall [***].

 

(c)          Prior to the Termination Date, Sandoz and Adamis, or Adamis’ designee, will use commercially reasonable efforts to enter
into a Transition Services Agreement for the post termination period. The Transition Services Agreement shall address such issues
as [***]. If, for any reason, the parties are unable to reach agreement on and execute the Transition Services Agreement prior
to the Termination Date, the terms of the Commercialization Agreement shall remain in full force and effect until the date that
the Transition Services Agreement is executed by the parties thereto, and the Termination Date shall be extended until such date.
During any such extension Sandoz shall not be required to [***] and will continue to [***]. Notwithstanding the foregoing, should
the Parties be unable to reach agreement on and execute the Transition Services Agreement within [***] of the Effective Date of
this Agreement, then the Commercialization Agreement shall be terminated [***] with no further obligations of either Party to negotiate
further.

 

     

     

    

 

3.            Consequences of Termination. Notwithstanding anything to the contrary contained in the Commercialization Agreement:

 

(a)          On the Termination Date, the licenses granted to Sandoz under the Commercialization Agreement shall immediately terminate and be
of no further force and effect, except as needed to provide services under the Transition Services Agreement and as set forth therein.

 

(b)          Sandoz
hereby assigns to Adamis all right, title, and interest in and to the Marketing Materials created or controlled by Sandoz for
the Products subject to the requirements of section 2(b).

 

(c)          Post Termination
True-Up: [***] after the Termination Date, Sandoz shall perform a “true-up” reconciliation of the items comprising
deductions from Net Sales. The reconciliation shall be based on [***]. Sandoz shall provide Adamis with a written report of such
reconciliation. If the foregoing reconciliation report shows either an underpayment or an overpayment between the Parties, the
Party owing the payment to the other Party shall pay the amount of the difference to the other Party within [***] after the date
of delivery of such report. This provision shall survive expiration or termination of this Agreement in accordance with the terms
hereof.

 

(d)          Notwithstanding anything to the contrary contained in the Commercialization Agreement, only the following provisions of the Commercialization
Agreement shall survive the termination of the Commercialization Agreement: [***].

 

All other provisions of the Commercialization Agreement that
do not expressly survive termination pursuant to Section 3(c) hereof shall terminate.

 

4.     Mutual Release. Except for those Claims covered by the surviving indemnities set forth in [***]:

 

(a)          Adamis hereby releases and discharges Sandoz and any and all of its parent companies, subsidiaries, affiliates, predecessors,
and/or successors, and any and all past or present directors, officers, representatives, principals, employees, insurers and attorneys,
assigns of any of the foregoing, from any and all claims, demands, liabilities, actions, rights, obligations, and causes of actions
of any nature, whether accrued or unaccrued, discovered or undiscovered, asserted or unasserted, direct or indirect, whether arising
in law or at equity, in any way arising out of or relating to or in connection with any Commercialization Agreement, the Products
and any obligations of Sandoz under the Commercialization Agreement, which they ever had, now have, or ever shall have; provided,
however, that nothing contained herein shall be construed to release any claims that Adamis may have against Sandoz for breach
of this Agreement.

 

     

     

    

 

(b)          Sandoz hereby releases and discharges Adamis and any and all of its parent companies, subsidiaries, affiliates, predecessors,
and/or successors, and any and all past or present directors, officers, representatives, principals, employees, insurers and attorneys,
assigns of any of the foregoing, from any and all claims, demands, liabilities, actions, rights, obligations, and causes of actions
of any nature, whether accrued or unaccrued, discovered or undiscovered, asserted or unasserted, direct or indirect, whether arising
in law or at equity, in any way arising out of or relating to or in connection with any Commercialization Agreement, the Products,
and any obligations of Adamis under the Commercialization Agreement, which they ever had, now have, or ever shall have; provided,
however, that nothing contained herein shall be construed to release any claims that Sandoz may have against Adamis for breach
of this Agreement or against Adamis or any third party for a breach of the Transition Services Agreement.

 

5.            Entire Agreement; Amendments. This Agreement, the Commercialization Agreement and the Schedules, Appendices and Exhibits
hereto and thereto constitute the entire agreement of the Parties with respect to the subject matter hereof and supersede all previous
arrangements with respect to the subject matter hereof, whether written or oral. In the event of any conflict between the terms
of this Agreement and the Commercialization Agreement, this Agreement shall control. This Agreement may be amended or modified
only by a written instrument duly executed by authorized representatives of both Parties hereto.

 

6.            Waivers. No delay or failure on the part of a Party in exercising or enforcing any right under this Agreement shall impair
or be construed as a waiver of any such right, or be construed as a waiver of any default, or shall affect the right of such Party
thereafter to enforce each and every provision of this Agreement in accordance with its terms, nor shall any waiver of any single
breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All waivers must be in
writing and shall be effective only to the extent specifically set forth in writing, and no course of dealing among the Parties
shall be deemed a waiver hereunder.

 

7.            Severability. If any provision of this Agreement is found to be unenforceable, the remainder shall be enforced as fully
as possible and the unenforceable provision shall be deemed modified to the limited extent required to permit its enforcement in
a manner most closely representing the intention of the parties as expressed herein.

 

8.            Successors and Assigns. Neither Party may assign this Agreement without the prior written consent of the other Party, except
that this Agreement and all of its rights and obligations may be assigned by either Party in connection with a Change in Control,
or in connection with the sale of all or substantially all of the assets to which this Agreement relates. Any purported assignment
in violation of this Section shall be null and void and of no effect. No assignment will release either Party from responsibility
for the performance of any accrued obligation of such Party hereunder. This Agreement will be binding upon and enforceable against
the successor to or any permitted assignee of either of the Parties.

 

9.            Notices. All communications, notices, instructions and consents provided for herein or in connection herewith shall be given
in accordance with Section 16.5 of the Commercialization Agreement to the applicable address set forth above.

 

10.          Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York,
including all matters of construction, validity and performance, in each case without reference to any conflict of law rules that
might lead to the application of the laws of any other jurisdiction.

 

     

     

    

 

11.          Exclusive Jurisdiction. Adamis and Sandoz agree to irrevocably submit to the exclusive jurisdiction of (a) the state courts
of New York County, New York, U.S.A., or (b) the United States District Court for the Southern District of New York, U.S.A., for
the purposes of any suit, action or other proceeding arising out of this Agreement or any transaction contemplated hereby. Each
Party agrees to commence any such action, suit or proceeding either in the United States District Court for the Southern District
of New York, U.S.A. or, if such suit, action or other proceeding may not be brought in such court for jurisdictional reasons, in
the state courts of New York County, New York, U.S.A. Each Party further agrees that service of any process, summons, notice or
document by US. registered mail or recognized international courier service to such Party’s respective address set forth
herein shall be effective service of process for any action, suit or proceeding in New York with respect to any matters to which
it has submitted to jurisdiction in this Agreement. Each Party irrevocably and unconditionally waives any objection to the laying
of venue of any action, suit or proceeding arising out of this Agreement or the transactions contemplated hereby in (i) the state
courts of New York County, New York, U.S.A., or (ii) the United States District Court for the Southern District of New York, U.S.A.,
and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action,
suit or proceeding brought in any such court has been brought in an inconvenient forum (e.g., under the doctrine of forum non conveniens
or pursuant to 28 U.S.C. § 1404(a)). Each Party hereto agrees that any such proceeding shall be conducted solely in the English
language.

 

12.          Counterparts; Electronic Signatures. This Agreement may be executed in two (2) or more counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via
facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.

 

     

     

    

 

IN WITNESS WHEREOF, the Parties have executed
this Agreement as of the date first set forth above.

 

	
        ADAMIS PHARMACEUTICALS CORP.

         

        By:        /s/ Dennis J. Carlo                                                   

         

        Name:   Dennis J. Carlo                                                        

         

        Title:     Chief Executive Officer                                          
	
        SANDOZ INC.

         

        By:        /s/ Karen McDonnell                                                                

         

        Name:   Karen McDonnell                                                                      

         

        Title:     VP & General CounselAdamis Pharmaceuticals Corporation 10-Q

     

Exhibit 10.2

 

*** Certain identified information has
been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant
if publicly disclosed. Such omitted information is indicated by brackets (“[...***...]” in this exhibit.
***

 

TRANSITION SERVICES AGREEMENT

 

BETWEEN

 

USWM, LLC,

 

ADAMIS PHARMACEUTICALS CORPORATION,

 

AND

 

SANDOZ INC.

 

June 1, 2020

 

     

     

    

 

TRANSITION SERVICES
AGREEMENT

 

This Transition Services
Agreement (the “Agreement”) is entered into as of June 1, 2020 (the “Effective Date”), by
and between Adamis Pharmaceuticals Corporation, a Delaware corporation, with an office located at 11682 El Camino Real, Suite #300,
San Diego, CA 92130 (“Adamis”), USWM, LLC, a Delaware
limited liability company, with an office at [***] (“USWM”) and Sandoz Inc., a Colorado corporation,
with offices at 100 College Road West, Princeton, New Jersey 08540 (“Sandoz”). Adamis, USWM and Sandoz are each
referred to individually as a “Party” and together as the “Parties”.

 

RECITALS

 

WHEREAS, USWM and Adamis
are parties to that certain Distribution and Commercialization Agreement dated as of May 11, 2020, pursuant to which USWM agreed,
inter alia, to purchase certain Products from Adamis for distribution and commercialization.

 

WHEREAS, Sandoz and
Adamis are parties to that certain Termination and Transfer Agreement, dated May 11, 2020 (as such agreement may be amended from
time to time, the “Termination Agreement”), terminating the Distribution and Commercialization Agreement between
the Parties, dated July 1, 2018 (the “Commercialization Agreement”) with a termination effective on the date
hereof.

 

WHEREAS, the Termination
Agreement provides, among other things, that Sandoz and Adamis, or Adamis’ designee, will use commercially reasonable efforts
to enter into a Transition Services Agreement to address certain rights with respect to [***] (the “Distribution Products”)
following the Effective Date and during the applicable Transition Term.

 

WHEREAS, in order to
ensure business continuity and to facilitate an effective transition of the Distribution Products to Adamis, Adamis and USWM desire
to receive from Sandoz certain services and support in the Territory for a specified period beginning on the Effective Date and
continuing for the Transition Term for each Service as set forth in the Transition Services Schedule.

 

WHEREAS, the services
and support described in this Agreement are in addition to those actions required under the Termination Agreement.

 

NOW, THEREFORE, in
consideration of the foregoing and the covenants and agreements set forth below, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:

 

ARTICLE
I

DEFINITIONS

 

The capitalized terms
used in this Agreement shall have the meanings as defined in this ARTICLE I.

 

    1

     

    

 

“Affiliate”
means, with respect to any Person, any Person which, directly or indirectly, controls, is controlled by, or is under common control
with, the specified Person. For the purposes of this definition, the term “control,” as applied to any Person, means
the possession, directly or indirectly, of the power to direct or cause the direction of the management of that Person, whether
through ownership of more than fifty percent (50%) voting securities or otherwise.

 

“Agreement”
shall have the meaning set forth in the preamble to this Agreement.

 

“Applicable Laws”
means all laws, ordinances, rules and regulations applicable to the Parties’ activities under this Agreement, and the obligations
of each Party as the context requires, including, without limitation: (a) all applicable federal, state and local laws and regulations
of the Territory; (b) the Federal Food, Drug and Cosmetic Act of 1938, including any amendments thereto and all regulations promulgated
thereunder or under any similar act or set of laws in the Territory; and (c) cGMP, as may be amended from time-to-time.

 

“Termination Agreement”
shall have the meaning set forth in the recitals.

 

“Adamis” shall
have the meaning set forth in the preamble to this Agreement.

 

“Business Day”
means any day that is not a Saturday, Sunday or other day on which commercial banks located in New York, New York are authorized
or required to be closed, as the case may be.

 

“cGMP” or
“Good Manufacturing Practices” means current good manufacturing practices as set forth in 21 C.F.R. Parts 210
and 211, as established by the FDA or any similar set of laws, regulations, rules, or practices in the Territory or otherwise applicable
to the manufacture, processing or supply of the Distribution Products pursuant to this Agreement.

 

“Claim” means
any claim, action, suit, demand or other legal assertion or proceeding brought by a Third Party against an indemnified party under
this Agreement related to any Liability.

 

“Designated Representative”
shall have the meaning set forth in Section 3.1.

 

“Distribute”,
“Distribution” and “Distributing” means, with respect to the Distribution Products, to market,
have marketed, distribute, have distributed, offer to sell, sell, commercialize, have commercialized and otherwise exploit the
Distribution Products in the Territory during the Term.

 

“Distribution Network”
shall have the meaning set forth in the Transition Services Schedule.

 

“Distribution Products”
shall have the meaning set forth in the recitals.

 

    2

     

    

 

 

“FDA” means
the United States Food and Drug Administration, or any successor agency thereto.

 

“Force Majeure Event”
shall have the meaning set forth in Section 12.1.

 

“Label” means
any package, packaging material, or label designed for use with the Distribution Products pursuant to the terms of this Agreement,
in accordance with Applicable Laws including the package insert for such Distribution Products, that is approved by the FDA.

 

“Labeling”
means applying a Label or a package insert to the Distribution Products, pursuant to the terms of this Agreement, in accordance
with Applicable Laws.

 

“Liability”
means all losses, costs, damages, judgments, settlements, interest, fees or expenses including, without limitation, all reasonable
attorneys’ fees, experts’ or consultants’ fees, expenses and costs, related to or arising from this Agreement
or any Services contemplated by this Agreement.

 

“Net Sales”
shall have the meaning set forth in the Transition Services Schedule.

 

“Party” and
“Parties” shall have the meaning set forth in the preamble to this Agreement.

 

“Post-Transition Term
True-Up” has the meaning set forth the Transition Services Schedule.

 

“Product Business”
means the operation and activities of the business specifically relating to the Distribution services conducted by or on behalf
of Sandoz for the Distribution Products in the Territory during the Term.

 

“Profit” shall
have the meaning set forth in the Transition Services Schedule.

 

“Quality Agreement”
shall have the meaning set forth in the Transition Services Schedule.

 

“Representative(s)”
shall have the meaning set forth in Section 6.3(c).

 

“Sandoz” shall
have the meaning set forth in the preamble to this Agreement.

 

“Service(s)”
shall have the meaning set forth in ARTICLE II.

 

“Term” shall have the meaning set
forth in ARTICLE IV.

 

“Territory” means the fifty states of the United States of America, the District of Columbia,
the Commonwealth of Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands and all territories and possessions of the United
States of America, United States military bases and any other territories the Parties mutually agree in writing to add to this
Agreement.

 

“Third Party” means any Person
other than a Party or any of its Affiliates.

 

    3

     

    

 

 

“Supply Price” means, with respect
to a Distribution Product, the price set forth opposite the name of such product as more fully set forth on Annex B attached
hereto.

 

“Transition Services
Schedule” shall have the meaning set forth in ARTICLE II.

 

“Transition Term” shall have the meaning
set forth in the Transition Services Schedule.

 

“USWM” shall have the
meaning set forth in the preamble of this Agreement.

 

ARTICLE
II

TRANSITION SERVICES SCHEDULE

 

Subject to the terms
and conditions of this Agreement, beginning on the Effective Date and continuing until the end of the applicable Transition Term,
Sandoz, either directly or indirectly through one or more of its Affiliates (or Third Parties, subject to the requirements of ARTICLE
IX), shall provide to Adamis and USWM services described in the schedule attached hereto as Annex A (the “Transition
Services Schedule”), in accordance with ARTICLE III, to ensure business continuity and to facilitate an effective transition
of [***] (collectively, the “Services”). For the avoidance of doubt, this Agreement applies only to Services
with respect to the Territory and not to any other country of the world. The Transition Services Schedule includes the following
information: [***]. The contact information for the group or personnel providing the Service will be specified during the Term.
The Transition Services Schedule shall be considered part of this Agreement and is incorporated herein by reference.

 

ARTICLE
III

SERVICES

 

3.1           Services Generally; Appointment of Sandoz as Distributor.

 

(a)          Sandoz shall provide, or cause to be provided, to Adamis and USWM the Services described herein and in the Transition Services
Schedule until expiration of the applicable Transition Term, in order to [***] and facilitate the transition of the activities
related to the Product Business to Adamis and USWM for each Service upon the conclusion of the applicable Transition Term for such
Service. The personnel providing Services shall be qualified for the applicable assigned tasks. Each Party shall appoint one or
more designated representatives to oversee and coordinate the implementation of each Service (the “Designated Representative”);
provided, however, that in the absence of such specific designation, the Designated Representative for Adamis and USWM shall be
[***]. Each Party shall have the right from time to time, by written notice to the other Party (including by e-mail), to change
the Designated Representative listed in the Transition Services Schedule. The Designated Representative shall be responsible for
coordinating the Services, as specified in the Transition Services Schedule.

 

(b)          During the Term, subject to the rights and conditions of this Agreement, Adamis and USWM hereby grant Sandoz the exclusive right
to [***]. Notwithstanding the foregoing, during the Term, Adamis and USWM shall not be permitted to [***].

 

    4

     

    

 

3.2           Service Limitations.

 

(a)          The Parties expressly acknowledge and agree that the obligation of Sandoz to provide transitional services following the Effective
Date is limited to the Services set forth in the Transition Services Schedule and services set forth in Annex C and there exists
no obligation on the part of Sandoz or any of its Affiliates to provide any other transitional or other services to Adamis and
USWM.

 

(b)          Except as provided in the Transition Services Schedule, the Services will be available for purposes of [***].

 

(c)          Nothing in this Agreement shall require Sandoz to obtain any additional licenses, systems, personnel or operations to provide or
comply with the obligations set forth in this Agreement.

 

(d)          Notwithstanding anything to the contrary in this Agreement, Adamis and USWM acknowledge and agree that the Services shall not be
resold or transferred; provided that Adamis may assign its rights hereunder in accordance with Section 14.9.

 

3.3          Exceptions to Obligations. The sole exceptions to the obligations of Sandoz to provide the Services as contemplated hereby
are to the extent (a) Sandoz cannot provide specified Services due to a Force Majeure Event, as determined under ARTICLE XII or
(b) providing the Services would be prohibited by Applicable Law.

 

ARTICLE
IV

TERM

 

The term of this Agreement
shall commence on the Effective Date and shall remain in effect until the expiration of the Transition Term as set forth in the
Transition Services Schedule unless earlier terminated under ARTICLE VII (the “Term”).

 

ARTICLE
V

COMPENSATION

 

5.1          Payment for Sandoz Services. In consideration for the Services, Adamis and USWM agree that Sandoz shall be permitted to
[***]. Adamis and USWM shall be responsible for the payment of [***].

 

5.2          Accounts and Records. Sandoz shall keep accounts and records of all activities carried out, and all costs and expenses incurred,
in the performance of its obligations under this Agreement consistent with the ordinary course and past practice of Sandoz. Sandoz
shall maintain, and shall provide as requested by Adamis and USWM, documentation and information reasonably requested by Adamis
and USWM to support [***].

 

    5

     

    

 

5.3          Audit. Beginning on the Effective Date and during the Term and for [***] thereafter, Adamis and USWM shall have the right,
within [***] after receipt by Sandoz of written request from Adamis or USWM, to have an independent certified public accounting
firm inspect Sandoz and/or its Affiliates (as applicable) records with respect to [***] for the sole purpose of determining [***].
Sandoz shall permit such independent certified public accounting firm to have reasonable confidential access, during normal business
hours and upon having given reasonable prior written notice, to such records of Sandoz and/or its Affiliates (as applicable) as
may be reasonably necessary to [***]. Except as otherwise provided herein, the audit shall be conducted at USWM or Adamis’
expense, as applicable. In the event that an examining auditor concludes any incorrect calculation of [***], the auditor will specify
such incorrect calculation [***] in a written report, along with the information on which such conclusion is based. This report
will be shared promptly with Sandoz. Sandoz shall remit any corresponding underpayments or reimburse any corresponding overpayment
to the underpaid or overcharged Party within [***] of the date of such report. Further, if the audit for an audited period shows
an underpayment or an overcharge by any Party for that period in excess of over both [***] and [***] of the amounts properly determined,
Sandoz shall reimburse the applicable underpaid or overcharged Party conducting the audit, for its respective audit fees and reasonable
out-of-pocket costs in connection with such audit, which reimbursement shall be made within [***] after receiving appropriate invoices
and other support for such audit-related costs.

 

ARTICLE
VI

GENERAL OBLIGATIONS; STANDARD OF CARE; INDEMNIFICATION

 

6.1          Performance Standards. Sandoz shall provide or cause the Services to be provided to the Adamis and USWM, (i) [***] (taking
into account [***]; and (ii) in accordance with Applicable Laws. Unless otherwise specified in the Transition Services Schedule
or otherwise mutually agreed by the Parties in writing, Sandoz shall perform Services [***] (taking into account [***]. Adamis
and USWM shall provide commercially reasonable resources and timely decisions, approvals and acceptances in order that Sandoz may
provide the Services [***] (taking into account [***].

 

6.2          Responsibility for Errors; Delays. Except for damages arising out of [***], subject to the remedies detailed in this Agreement
(including Article XI), Sandoz’ sole responsibility to Adamis and USWM with respect to errors, omissions and delays of the
Services, or failure to provide the Services, is as
follows:

 

(a)          for errors or omissions in Services, to furnish correct information, payment and/or adjustment in the Services, at no additional
cost or expense; provided, that Adamis or USWM shall promptly advise Sandoz of any such error or omission of which it becomes aware
after having used commercially reasonable efforts to detect any such errors or omissions in the Services furnished by Sandoz; provided,
further, that Sandoz’ obligation with respect to ensuring compliance with this Section 6.2(a) by its Affiliates and/or subcontractors
will be limited to using its commercially reasonable efforts to assure compliance with this Section 6.2(a) by its Affiliates and/or
subcontractors; and

 

(b)          for failure of Sandoz to deliver any Service, to use commercially reasonable efforts to remedy or make the Services available and/or
to resume performing the Services as promptly as reasonably practicable.

 

    6

     

    

 

6.3          Good Faith Cooperation; Confidentiality.

 

(a)          Subject to the terms and conditions contained herein, during the Term, the Parties will use good faith efforts to cooperate with
each other to provide the Services contemplated hereby and, if necessary for the provision of such Services, shall use commercially
reasonable efforts to exchange information and perform reconciliations and adjustments required to ensure business continuity and
to facilitate an effective transition of the Distribution Products to Adamis and USWM, in each case subject to appropriate and
customary confidentiality restrictions as the providing Party may request.

 

(b)          The Parties will maintain, in accordance with their standard document retention procedures, documentation supporting the information
relevant to [***], and will use their commercially reasonable efforts to cooperate with each other in making such information available
as needed in the event of a tax audit.

 

(c)          For purposes of this Agreement, “Confidential Information” means, with respect to a Party, all confidential
and proprietary know-how, scientific information, clinical data, efficacy and safety data, formulas, methods and processes, specifications,
pricing information (including discounts, rebates and other price adjustments), and other terms and conditions of sales, customer
information, business plans, and all other intellectual property), and all non-public information of the other Party, which is
disclosed or made available to the other Party regardless of whether such information is marked, identified as or otherwise acknowledged
to be confidential at the time of disclosure to the other Party. The Receiving Party shall (i) treat as confidential all Confidential
Information of the other Party or its Affiliates that comes to the receiving Party’s knowledge through this Agreement, and
(ii) not use the Disclosing Party’s Confidential Information, or permit it to be accessed or used, for any purpose other
than to exercise its rights or perform its obligations under this Agreement. The Parties hereby acknowledge that any such Confidential
Information may be used solely if and as required to perform or receive Services and other assistance pursuant to this Agreement.
The Receiving Party shall restrict access to Confidential Information to those of its Affiliates and any directors, officers, employees,
agents or representatives (each, a “Representative” and collectively, the “Representatives”)
of such Party or its Affiliates as are directly involved in the performance or receipt of the Services or other assistance pursuant
to this Agreement (who may include attorneys, accountants and other consultants employed by a Party in connection with the performance
or receipt of the Services or other assistance under this Agreement), it being understood that they shall be informed by the Receiving
Party of the confidential nature of any Confidential Information and shall be bound by obligations of confidentiality and non-use
at least as great in scope as those contained herein. Each Party shall be liable for any breach of this Agreement by any of its
Representatives. The Receiving Party shall take such steps to prevent disclosure of such Confidential Information to any Third
Party (except to the extent that such disclosure is necessary to provide the Services under the terms of this Agreement) as it
would take in protecting its own Confidential Information and shall not use any portion of such Confidential Information for any
purpose not authorized herein.

 

6.4          Indemnification. Each Party shall indemnify and hold the other Parties harmless from and against any Liability paid
or payable by such Parties to a Third Party as a result of any Claim that results from, arises out of or is based on the negligence
or willful misconduct of the indemnifying Party its officers, directors, agents, servants and employees in the performance under
to this Agreement.

 

    7

     

    

 

 

ARTICLE
VII

TERMINATION

 

7.1          Termination. This Agreement shall terminate automatically upon expiration or termination of the Term. This Agreement may
be terminated, in whole or in part, at any time:

 

(a)          by the mutual consent of Adamis, USWM and Sandoz;

 

(b)          by either Adamis, USWM, or Sandoz (provided that the terminating Party is not then in material breach of any covenant or other
agreement contained herein), by written notice to the other Party, if there shall have been a material breach of any of the provisions
of this Agreement by the other Party; provided, however, that a Party may only terminate the Agreement under this clause (b) if
(i) such breach has not been waived by the terminating Party in writing and (ii) such breach has not been cured within [***] following
the terminating Party’s written notice of such breach (provided, that, if such breach cannot reasonably be cured within [***]
and the breaching Party is diligently proceeding to cure such breach, such Party’s cure period shall be extended for such
period of time as may be reasonably required, up to [***] in the aggregate); or

 

(c)          by either Party, by written notice to the other Party, upon the filing or institution of bankruptcy, reorganization, liquidation
or receivership proceedings, or upon an assignment of a substantial portion of the assets for the benefit of creditors by the other
Party; provided, however, that in the case of any involuntary bankruptcy proceeding, such right to terminate shall only become
effective if such Party consents to the involuntary bankruptcy or such proceeding is not dismissed within [***] after the filing
thereof.

 

7.2          Survival. ARTICLE V, ARTICLE X, ARTICLE XI, ARTICLE XIII, ARTICLE XIV and Sections 6.2 and this 7.2 shall survive termination
of this Agreement. Notwithstanding the foregoing, in the event of any termination with respect to one or more, but less than all,
Services, this Agreement shall continue in full force and effect with respect to any Services under that portion of the Transition
Services Schedule not terminated.

 

ARTICLE
VIII

REPRESENTATIONS AND WARRANTIES

 

8.1          Authorization. Each Party hereby represents and warrants that (a) it has the requisite power and authority to execute and
deliver this Agreement and to perform the transactions contemplated hereby, (b) all corporate action on the part of such Party
necessary to approve or to authorize the execution and delivery of this Agreement and the performance of the transactions contemplated
hereby to be performed by it has been duly taken, (c) this Agreement is a legal, valid and binding agreement of such Party, enforceable
in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and
other similar laws affecting creditors’ rights generally from time to time in effect and to general principles of equity
(including concepts of materiality, reasonableness, good faith and fair dealing), regardless of whether considered in a proceeding
in equity or at law.

 

    8

     

    

 

8.2          No Breach or Conflict. Each Party hereby represents and warrants that (a) its execution and delivery of this Agreement and
its and its Affiliates’ performance of its obligations hereunder does not and shall not conflict with, result in a breach
of, constitute a default under, or require the consent of any Third Party under, any license, sublicense, lease, contract, agreement,
or instrument to which it or any of its Affiliates is bound, and (b) it has obtained all Third Party consents, authorizations and
approvals from any Third Party licensor or contractual counterparty or any other Third Party that is necessary to perform its obligations
hereunder.

 

8.3          Compliance with Applicable Law. Each Party hereby represents and warrants that it shall perform its obligations under this
Agreement in a manner that complies with all Applicable Laws.

 

8.4          Compliance with Good Manufacturing Practices. Sandoz hereby represents and warrants that it shall manufacture and store
the Distribution Products in a manner that complies with cGMP.

 

ARTICLE
IX

SUBCONTRACTORS

 

Subject to Section
3.1, any Party hereto may engage a Third Party or an Affiliate to perform all or any portion of its duties under this Agreement
provided that: (a) any such Third Party agrees in writing to be bound by confidentiality obligations and (b) the Party so engaging
a Third Party remains responsible for the performance of each such Third Party or Affiliate, and the compliance of each such Third
Party and Affiliate with all applicable provisions of this Agreement.

 

ARTICLE
X

INTELLECTUAL PROPERTY

 

The Parties do not anticipate that this
Agreement or the performance of Services will affect the ownership of the intellectual property rights of either Party.

 

ARTICLE
XI

LIMITATION OF LIABILITY; INDEMNIFICATION

 

11.1       Limitation
of Liability. NO PARTY SHALL BE LIABLE TO OR OTHERWISE RESPONSIBLE TO ANY OTHER PARTY HERETO OR ANY AFFILIATE OF ANY OTHER
PARTY HERETO FOR ANY INCIDENTAL, SPECIAL, CONSEQUENTIAL, INDIRECT, EXEMPLARY OR PUNITIVE DAMAGES THAT ARISE OUT OF OR RELATE TO
THIS AGREEMENT OR THE PERFORMANCE OR BREACH HEREOF, WHETHER SUCH DAMAGES OR OTHER RELIEF ARE SOUGHT BASED ON BREACH OF CONTRACT,
NEGLIGENCE, STRICT LIABILITY OR ANY OTHER LEGAL OR EQUITABLE THEORY AND WHETHER OR NOT THE PARTY WAS AWARE OR ADVISED OF THE POSSIBILITY
OF SUCH DAMAGES. THE FOREGOING SHALL NOT APPLY TO (A) DAMAGES RESULTING FROM A PARTY’S FRAUD,
GROSS NEGLIGENCE OR WILLFUL MISCONDUCT, OR (B) THE PARTIES’ RESPECTIVE INDEMNIFICATION OBLIGATIONS SET FORTH
IN THE Termination Agreement.

 

    9

     

    

 

11.2       Exclusive Remedy. Except as set forth in Section 6.2 of this Agreement, the sole and exclusive remedy
for any and all Claims arising under, out of, or related to this Agreement and the transactions contemplated hereby shall be the
rights of indemnification set forth in Section 6.4 of this Agreement only, and no Person will have any other entitlement, remedy
or recourse, whether in contract, tort or otherwise, it being agreed that all of such other remedies, entitlements and recourse
are expressly waived and released by the Parties hereto to the fullest extent permitted by Applicable Law.

 

ARTICLE
XII

FORCE MAJEURE

 

12.1        Force Majeure Event. Neither Party nor any of its Affiliates (nor any Person acting on its or their behalf) shall bear any
responsibility or liability for any losses arising out of any delay, inability to perform or interruption of its performance of
obligations under this Agreement due to events beyond the reasonable control of such Party or its Affiliates (or any Person acting
on its or their behalf) for a Force Majeure Event (as defined below). In such event, the obligations hereunder of Sandoz in providing
the impacted Service or performing its obligations under this Agreement, and the obligation of Adamis to pay for the same, shall
be postponed for such time as its performance is suspended or delayed on account thereof but only to the extent that the Force
Majeure Event prevents the affected Party (or its affected Affiliate(s)) from performing its duties and obligations hereunder.
During the duration of the Force Majeure Event, the affected Party shall use all commercially reasonable efforts to avoid or remove
such Force Majeure Event and shall use all commercially reasonable efforts to resume its performance under this Agreement with
the least practicable delay. A “Force Majeure Event” means any event which is beyond the reasonable control
of the Party affected, including the following events: earthquake, storm, flood, fire or other acts of nature, epidemic, war, riot,
public disturbance, strike or lockouts, government actions, terrorist attack or the like.

 

ARTICLE
XIII

GOVERNING LAW

 

13.1        Governing Law; English Language. This Agreement shall be governed, interpreted and construed in accordance with the substantive
laws of the State of Delaware, U.S.A., without regard to its conflict of laws principles. In the event any translation of this
Agreement is prepared for convenience or for any other purpose, the provisions of the English version shall prevail.

 

13.2        Arbitration. Any disputes arising out of or in connection with this Agreement shall be
resolved by final and binding arbitration before a panel of one arbitrator with relevant industry experience. The arbitration proceeding
shall be administered in accordance with the Commercial Arbitration Rules of the American Arbitration Association (“AAA”),
and the panel of arbitrators shall be selected in accordance with such rules. The arbitration and all associated discovery proceedings
and communications shall be conducted in English, and the arbitration shall be held in a reasonable location to be selected by
the Party against whom arbitration is compelled. The legal place of arbitration shall be New York, NY, USA. The language
of the arbitration shall be English.

 

    10

     

    

 

ARTICLE
XIV

MISCELLANEOUS

 

14.1        Expenses. Except as otherwise specified in this Agreement or the Transition Services Schedule, all costs and expenses, including
fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement and the transactions
contemplated hereby or thereby will be paid by the Party incurring such costs and expenses.

 

14.2        No Third Party Beneficiaries. Except as specifically provided herein, this Agreement is not intended to confer upon any
Person other than the Parties hereto any rights or remedies hereunder.

 

14.3        Entire Agreement. This Agreement, the Termination Agreement, the other Ancillary Agreements and the Transition Services
Schedule hereto constitute the entire agreement among, and supersede all prior agreements and understandings, both written and
oral, between or among the Parties with respect to the subject matter hereof. Notwithstanding the above, nothing in this Agreement
shall be deemed to modify or otherwise amend the rights and obligations of the Parties in the Termination Agreement and to the
extent there is deemed to be a conflict between this Agreement and the Termination Agreement, the provisions of the Termination
Agreement, as applicable, shall control. In the event of any conflict between the terms of this Agreement and the Annexes hereto,
the terms of the Annexes shall govern.

 

14.4        Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original
but all of which, taken together, shall constitute one and the same instrument. PDF and facsimile signatures shall constitute original
signatures. The Parties agree that any electronic signatures appearing on this Agreement are the same as handwritten signatures
for the purposes of validity, enforceability and admissibility pursuant to the Electronic Signatures in Global and National Commerce
(ESIGN) Act of 2000, and Uniform Electronic Transactions Act (UETA) model law, or similar Applicable Laws.

 

14.5        Headings. The headings contained in this Agreement are for reference purposes only and will not affect in any way the meaning
or interpretation of this Agreement.

 

14.6        Notices. All notices and other communications required or permitted to be given or made pursuant to this Agreement shall
be in writing signed by the sender and shall be deemed duly given (a) on the date delivered, if personally delivered, (b) on the
date sent by telecopier with automatic confirmation by the transmitting machine showing the proper number of pages were transmitted
without error, (c) on the Business Day after being sent by Federal Express or another recognized overnight mail service which utilizes
a written form of receipt for next day or next Business Day delivery or (d) three (3) Business Days after mailing, if mailed by
U.S. postage-prepaid certified or registered mail, return receipt requested, in each case addressed to the applicable Party at
the address set forth below; provided that a Party may change its address for receiving notice by the proper giving of notice hereunder:

 

    11

     

    

 

If to Adamis, to:

Adamis Pharmaceuticals Corporation

11682 El Camino Real, Suite 300

San Diego, California 92130

Attention: President and CEO

 

If to USWM, to:

	
        USWM, LLC

        [***]

        [***]

        Attn: [***]
	 
	 	 
	With a copy to (which shall not constitute notice) 
	 
	
        USWM, LLC 

	[***]
	[***]
	Attn:  [***]
	Tel:  [***]
	Email:  [***]

 

If to Sandoz to:

Sandoz Inc.

[***]

[***]

Attention: President

 

With a copy (which shall not constitute
notice) to:

 

Sandoz Inc.

[***]

[***]

Attention: [***]

 

14.7        Amendments and Waivers. This Agreement may only be amended by an instrument in writing signed on behalf of each of the Parties.
By an instrument in writing, Adamis and USWM, on the one hand, or Sandoz, on the other hand, may waive compliance by the other
Party with any term or provision of this Agreement that such other Party was or is obligated to comply with or perform. The failure
of any Party to assert a right hereunder or to insist upon compliance with any term of condition of this Agreement shall not constitute
a waiver of that right or excuse for a similar failure to perform any such term or condition by the other Party.

 

14.8        Severability. Should any part or provision of this Agreement be held unenforceable or in conflict with Applicable Law, the
invalid or unenforceable part or provision shall, provided that it does not affect the essence of this Agreement, be replaced with
a revision which accomplishes, to the greatest extent possible, the original commercial purpose of such part or provision in a
valid and enforceable manner, and the balance of this Agreement shall remain in full force and effect and binding upon the Parties
hereto.

 

    12

     

    

 

14.9        Binding Effect; Assignment. The terms and provisions hereof shall inure to the benefit of, and be binding upon the Parties
and their respective successors and permitted assigns. No Party shall assign, encumber or otherwise transfer this Agreement or
any part of it to any third party, without the prior written consent of the other Party which consent will not be unreasonably
withheld; provided, however, that notwithstanding the foregoing, no such consent shall be required in the event of any assignment
or transfer of this Agreement by either Party (a) to any of its Affiliates, or (b) to any successor in interest to such Party’s
business, whether by merger, sale of assets or otherwise; in the event of which a Party shall only be required to give written
notice of such assignment or transfer to the other Party but will not be required to obtain the consent of the other Party. In
the case of any sale, assignment, divestiture or other transfer, the assigning Party shall remain liable for the full and timely
performance of the transferee.

 

14.10     
Further Assurances and Actions. Each of the Parties, upon the request of the other Party and without further consideration,
will do, execute, acknowledge and deliver, or cause to be done, executed, acknowledged or delivered, any and all such further acts,
deeds, documents, assignments, transfers, conveyances, powers of attorney and assurances as may be reasonably necessary to effect
complete consummation of the transactions contemplated by this Agreement and
the Termination Agreement. Sandoz and Adamis agree to execute and deliver such other documents, certificates, agreements
and other writings and to take such other actions as may be reasonably necessary in order to consummate or implement expeditiously
the transactions contemplated by this Agreement and the Termination
Agreement. If requested, each Party shall confirm receipt of any notice that it receives by any of the methods of
delivery described in Section 14.6.

 

14.11     
Relationship between the Parties. The relationship between the Parties established under this Agreement is that of independent
contractors, and neither Party shall be deemed an employee, agent, partner or joint venturer of or with the other. Employees of
Sandoz involved in the provision of Services under this Agreement shall remain employees of Sandoz and Sandoz will be solely responsible
for any employment-related taxes, insurance premiums or other employment benefits applicable to such employees.

 

14.12     
Interpretation. For purposes of this Agreement, (a) the words “include,” “includes” and “including”
shall be deemed to be followed by the words “without limitation,” (b) the word “or” is not exclusive
and (c) the words “herein,” “hereof,” “hereby,” “hereto” and “hereunder”
refer to this Agreement as a whole. Unless the context otherwise requires, references herein: (i) to clauses or annexes mean the
clauses of, and annexes to, this Agreement, (ii) to an agreement, instrument or other document means such agreement, instrument
or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof, and
(iii) to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations
promulgated thereunder. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation
against the Party drafting an instrument or causing any instrument to be drafted. The annexes referred to herein shall be construed
with, and be an integral part of, this Agreement to the same extent as if they were set forth herein.

 

    13

     

    

 

14.13     
Specific Performance. The Parties agree that irreparable damage would occur if any provision of this Agreement were not
performed in accordance with the terms hereof and that the Parties shall be entitled to seek specific performance of the terms
hereof.

 

[Signature Page Follows]

 

    14

     

    

 

IN WITNESS WHEREOF,
each Party has caused this Agreement to be executed on its behalf by its duly authorized representatives on the day and year first
above written.

 

	 	ADAMIS PHARMACEUTICALS CORPORATION
	 	 	 
	 	By:	/s/ Dennis J. Carlo
	 	 	Name:  Dennis J. Carlo
	 	 	Title:  Pres/CEO
	 	 	Date: 6/1/2020
	 	 	 
	 	USWM, LLC
	 	 	 
	 	By:	/s/ H. Lee Warren, Jr.
	 	 	Name:  J. Lee Warren, Jr.
	 	 	Title:  COO
	 	 	Date:  6/1/2020
	 	 	 
	 	SANDOZ INC.
	 	 	 
	 	By:	/s/ Sheila Frame
	 	 	Name:  Sheila Frame
	 	 	Title:  VP Marketing, Market Access, and Patent Access
	 	 	Date:  02-Jun-20

 

Signature Page to Transition Services Agreement

 

     

     

    

 

ANNEX A

 

TRANSITION SERVICES SCHEDULE

 

		1.	Distribution Services.

 

Transition Term: For the
period beginning on the Effective Date and ending on [***] (the “Transition Term”). The Transition Term may
be extended for an additional [***] through prior written notice by Adamis and/or USWM to Sandoz provided [***].

 

Description: Subject to
Section 3.1(b) of this Agreement and the transactions contemplated in the Termination Agreement, Sandoz or its Affiliates shall
[***]; provided, that, notwithstanding anything to the contrary in this Agreement, Sandoz shall not [***] (i) [***] or (ii) [***].
Sandoz or its Affiliates shall [***]. Sandoz and USWM shall [***]. The Parties shall be permitted to [***]. At the conclusion of
the Transition Term Sandoz may [***].

 

Distribution Products:
List provided on Annex B.

 

Cost: During the Transition Term, subject to
Section 3.1(b), Adamis, USWM and/or their respective Affiliates and designees are not authorized to [***]. As such, Sandoz or its
Affiliates shall [***]. Sandoz shall [***], where [***] is calculated as follows [***]:

 

		a)	[***];

 

		b)	[***]; and

 

		c)	[***].

 

“[***]”
means, for each applicable calendar quarter during the Term, [***].

 

With respect to the calculation
of [***]: (i) [***]; and (ii) [***]. For clarity, within sixty (60) days following the end of each [***], [***] shall pay [***].
A written summary of [***] shall be provided by [***] to [***] within [***] following the end of [***].

 

Additional Costs: [***]
shall bear [***], including but not limited [***] for (a) [***]; and (b) [***].

 

“Post Transition Term
True-Up”: [***] after the end of the Term, Sandoz shall perform a “true-up” reconciliation of the items comprising
[***] (the “Post-Transition Term True-Up”). The reconciliation shall be based on [***]. Sandoz shall provide
USWM with a written report of such reconciliation. If the foregoing reconciliation report shows either an underpayment or an overpayment
between the Parties, the Party owing the payment to the other Party shall pay the amount of the difference to the other Party within
[***] after the date of delivery of such report. This provision shall survive expiration or termination of this Agreement in accordance
with the terms hereof.

 

    A-1 

     

    

 

Transition Term Orders:
Except as otherwise set forth herein, USWM shall be responsible for [***]. [***] shall [***] and [***] shall [***]. The [***] shall
be issued to [***] prior to [***]. For the avoidance of doubt, other than with respect to [***], [***] shall not [***]. For purposes
of clarity, with respect to [***] (i) [***] shall only be responsible for the invoice associated with 9,000 units from batch EP0035,
and (ii) [***] shall be responsible for [***].

 

Quality Agreement: The
Quality Agreement between the parties shall remain in full force and effect until [***].

 

Labelling;
Packaging: The Parties acknowledge and agree that [***]. Notwithstanding the foregoing, [***] shall make any changes during
[***] to [***]; provided, that [***] shall [***]. For the avoidance of doubt, [***] shall be under no obligation to [***].

 

Designated
Representatives:

 

Sandoz Representative:
[***]

 

Adamis
Representative: [***]

 

USWM
Representative: [***]

 

    A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]